Botched Deal Follows AAIPharma's Solvency
AAIPharma filed for bankruptcy in May 2005, listing assets of $323.3 million and debts of $446.7 million. Its reorganization plan was approved in January by Judge Peter J. Walsh of the U.S. Bankruptcy Court for the District of Delaware.
The North Carolina-based drug maker emerged as a privately held...
To view the full article, register now.